DD
42
-3
NKE
31
-3
HIG
50
-2
VNO
50
-2
F
40
-2
CCL
57
-3
HCP
52
-2
IVZ
48
-2
NWS
64
-9
IPG
39
-4
TRV
39
-3
IRM
31
-3
GD
42
-2
CL
47
-3
BXP
39
-3
PGR
49
-5
KMB
30
-3
BLK
52
-2
AMG
54
-3
AIZ
66
-2
DD
42
-3
NKE
31
-3
HIG
50
-2
VNO
50
-2
F
40
-2
CCL
57
-3
HCP
52
-2
IVZ
48
-2
NWS
64
-9
IPG
39
-4
TRV
39
-3
IRM
31
-3
GD
42
-2
CL
47
-3
BXP
39
-3
PGR
49
-5
KMB
30
-3
BLK
52
-2
AMG
54
-3
AIZ
66
-2
Financhill
Back

Black Diamond Therapeutics 10K Form

Sell
45

BDTX
Black Diamond Therapeutics

Last Price:
$2.20
Seasonality Move:
9.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDTX News And Ratings

See the #1 stock for the next 7 days that we like better than BDTX

BDTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-11.3M
Price / Cash Flow: 0
Annual Sales: $1.72
Price / Book: 1.27

Profitability

EPS (TTM): -1.33000
Net Income (TTM): $-73.1M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Black Diamond Therapeutics Earnings Forecast

Key Black Diamond Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Black Diamond Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDTX
CUSIP: 09203E
Website: blackdiamondtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDTX Technical Analysis vs Fundamental Analysis

Sell
45
Black Diamond Therapeutics (BDTX) is a Sell

Is Black Diamond Therapeutics a Buy or a Sell?